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The PrPC protein, which is especially present in the cellular membrane of nervous system cells, has been
extensively studied for its controversial antioxidant activity. In this study, we elucidated the free radical
scavenger activity of puriﬁed murine PrPC in solution and its participation as a cell protector in astrocytes
that were subjected to treatment with an oxidant. In vitro and using an EPR spin-trapping technique, we
observed that PrPC decreased the oxidation of the DMPO trap in a Fenton reaction system (Cu2+/ascor-
bate/H2O2), which was demonstrated by approximately 70% less DMPO/OH. In cultured PrPC-knockout
astrocytes from mice, the absence of PrPC caused an increase in intracellular ROS (reactive oxygen spe-
cies) generation during the ﬁrst 3 h of H2O2 treatment. This rapid increase in ROS disrupted the cell cycle
in the PrPC-knockout astrocytes, which increased the population of cells in the sub-G1 phase when com-
pared with cultured wild-type astrocytes. We conclude that PrPC in solution acts as a radical scavenger,
and in astrocytes, it is essential for protection from oxidative stress caused by an external chemical agent,
which is a likely condition in human neurodegenerative CNS disorders and pathological conditions such
as ischemia.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The cellular prion protein PrPC is a membrane glycoprotein that
is expressed in all cell types, although its expression is consistently
higher in the nervous system cells [1–3]. The variety of functions
that have been proposed for PrPC include oxidative stress [4]; im-
mune modulation [5]; differentiation [6]; translocation of metals,
such as copper [7]; alteration of copper, zinc and iron homeostasis
in the brain [8]; cell adhesion; and transmembrane signaling [3].
The N-terminus PrPC is a region with four or ﬁve repeats of the
amino acid sequence PHGGGWGQ, the octapeptide repeat region,
which is known to complex with copper ions in its structure [9–
12]. Copper(II) likely binds outside of this octapeptide repeat do-
main [13]. The ability to form this complex is also linked to pH
and the concentration of metals in the medium [14,15]. At low me-
tal concentrations, the protein forms a ‘‘wraparound’’ cover by
linking several histidines in its sequence. As the pH is related to
the metal content at physiological concentrations, up to four cop-
per ions can bind the deprotonated nitrogen atoms of imidazole
groups from histidines in the HGGG regions of the octapeptide re-lsevier OA license. 
Cerchiaro).peat domain [16], and two copper ions are associated to histidines
96 and 111 in the peptide sequence [17].
Copper is a micronutrient essential for cell survival because it
functions as a cofactor for several metalloenzymes. In relation to
PrPC, the octapeptide repeat domain can trap 4 or 5 copper(II) ions,
which can alter the redox potential of copper [14]. In fact, copper
has two redox states, copper(I) and copper(II); it efﬁciently cata-
lyzes redox cycles in the presence of endogenous oxygen and
hydrogen peroxide, and it generates partially reduced and highly
reactive O2 derivatives, which are known as reactive oxygen spe-
cies (ROS) [18]. The in vivo antioxidant activities of PrPC have been
the subject of intense debate [19–26]. In fact, it has been estab-
lished that PrPC generates a positive response in cells to oxidative
stress. Brown and co-workers have demonstrated that Prnp0/0 mice
have a speciﬁc cellular phenotype that leads to increased vulnera-
bility to oxidative stress associated with a decrease in superoxide
dismutase activity in neurons and astrocytes [27].
PrPC function has been largely studied in neurons, and the
importance of PrPC expression in astrocytes has only recently
emerged. Neurons are particularly sensitive to hydrogen peroxide
(H2O2), but the neurotoxic effect of H2O2 on neurons co-cultured
with astrocytes is strongly attenuated; the protective effect of
astrocytes depends on the ratio of astrocytes to neurons.
Consequently, astrocytes are believed to delay neuronal death in
pathological situations in which H2O2 has been, at least partially,
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activity that protects the neuronal cells from hydrogen peroxide
resides in astrocytes. Notably, it has been demonstrated that
wild-type astrocytes for PrPC secrete certain factors, including PrPC,
that are essential for neuronal survival in both wild type and PrPC-
null cells [29].
The objective of this work is to evaluate the protective role of
PrPC against and ROS generation and oxidative stress from hydro-
gen peroxide in the cell cycle in a new astrocyte cell line derived
from PrPC knockout mice and the wild-type counterpart, which
validates the antioxidant activity of PrPC in solution.2. Methods
2.1. Chemicals
Reagents were purchased from Sigma–Aldrich, Merck, Invitro-
gen, Millipore and Fisher Scientiﬁc. Solutions were prepared with
distilled water puriﬁed using a Millipore Milli-Q system (Millipore,
Bedford, MA, USA). The reagent 5,5-dimethyl-1-pirroline-N-oxide
(DMPO, from Sigma) was previously puriﬁed as recommended
[30].
2.2. Mouse PrPC expression and isolation
The expression vector containing the cDNA fragment that en-
codes amino acids 23–231 from the mouse PrPc protein cloned into
the pRSET (Invitrogen™) BamHI–EcoRI restriction sites was kindly
provided by Ralph Zahn (Institut für Molekularbiologie und Bio-
physik, Eidgenössische Technische Hochschule, Switzerland).
Expression, puriﬁcation and elution of His6-PrPc were performed
as previously described [31]. PrPCdel[51-91] was obtained as previ-
ously described [32].
2.3. EPR (electron paramagnetic resonance) spin trapping experiments
with PrPC in solution
The EPR spectra were recorded using a Bruker EMX instrument
operating at X-ray frequency (9.32 GHz; modulation frequency,
100 kHz; power, 20 mW). In the spin trapping EPR experiments,
puriﬁed DMPO (Sigma–Aldrich) was used as a spin scavenger.
The EPR spectra were generated from a mixture containing an oxi-
dant system that generates ROS (15 lM copper(II)sulfate/3 mM
hydrogen peroxide/15 lM ascorbate/phosphate buffer solution,
pH 7.4) with and without puriﬁed mouse wt PrPC (3.5 lM). Protein
concentrations from 2 to 100 lMwere tested, and the difference in
oxidation compared with the control experiment (without PrPC)
was demonstrated by the generation of between 45% and 70% less
[DMPO-OH] adduct. The concentration of 3.5 lM generated the
greatest reduction in adduct formation (70% less). Estimations for
DMPO-OH adduct generation were obtained by double integration
using the WinEPR Program (Bruker) and a TEMPOL (4-hydroxy-
TEMPO, where TEMPO is 2,2,6,6-tetramethyl-1-pipe-ridinyloxy;
Sigma–Aldrich) solution as the standard for calibration.
2.4. Cultured astrocytes from PrPC knockout and wild-type mice
We worked with a line of PrPC-null animals, which are desig-
nated in this study as Prnp0/0 (ZrchI) [33], and its wild-type control,
Prnp+/+ (ZrchI).
The astrocyte primary cultures were prepared as previously de-
scribed [34] from the cerebral hemispheres of embryonic day 17
(E17) wild type and PrPC-knockout mice. Brieﬂy, single cell suspen-
sions were obtained by dissociating cells from cerebral hemi-
spheres in Dulbecco’s minimum essential medium (DMEM)supplemented with glucose (33 mM), glutamine (2 mM), penicil-
lin/streptomycin (100 IU/100 lg/ml), and sodium bicarbonate
(3 mM). The cells were added to plates pre-coated with poly-L-ly-
sine (5 lg/ml) and grown in DMEM enriched with 10% fetal calf
serum (FCS). The cultures were incubated at 37 C in a humidiﬁed
5% CO2-95% air atmosphere, and the medium was changed every
2 days until the cells were 90% conﬂuent.
The immortalized astrocyte cell lines generated in this study
were maintained in DMEM supplemented with glucose (33 mM),
glutamine (2 mM), penicillin/streptomycin and sodium bicarbon-
ate (3 mM). The primary astrocytes were immortalized based on
the protocol described by Morikawa with slight modiﬁcations
[35]. The cells were transfected with the plasmid pSV3-neo (ATCC),
which encodes the SV40 T antigen early regions and neomycin
resistance, using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s protocol. Two days after transfection, G418
was added to the astrocytes and then gradually increased over
3 weeks until all of the non-transfected cells had died. Hence, the
cells were maintained for two weeks at the highest G418 concen-
tration, 2.08 mg/ml for Prnp0/0 and 0.96 mg/ml for Prnp+/+. The
immortalized cells were tested for over 40 passages. The immortal-
ized astrocytes are referred to as WKO and WWT and were derived
from Prnp0/0 and Prnp+/+ animals, respectively. The cells were incu-
bated in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM, from Sig-
ma–Aldrich) supplemented with 10% fetal bovine serum (from
Gibco), 100 U/ml penicillin and 10.0 lg/ml streptomycin (from Sig-
ma–Aldrich). Both the WWT and WKO cells were routinely re-pla-
ted at a density of 4  104 cells/cm2.
2.5. Fluorescence measurements
The WWT and WKO cells were plated in a 96 well-plate at a
density of 4  104 cells/cm2 to generate monolayers and incubated
with hydrogen peroxide (3.0 mM) for 3, 6 and 24 h under the con-
ditions described above. Following incubation, the cells were
washed three times with PBS (137 mM NaCl and 2.7 mM KCl in
10 mM phosphate buffer at pH 7.4) and treated with a 50.0 lM
solution comprising the oxidation-sensitive non-ﬂuorescent probe
20,70-dichlorodihydro-ﬂuorescein diacetate (DCFH-DA; Sigma–Al-
drich). Following an incubation at 37 C for 45 min [36,37], the
cells were washed three times with PBS, and the levels of intracel-
lular ﬂuorescence were determined immediately using a Varian
Cary Eclipse Fluorescence Spectrophotometer at 525 nm. The as-
says were conducted in quintuplicate.
2.6. Flow cytometry to determine cell cycle progression
Analysis of cell cycle progression was performed according to
Nicoletti et al. [38]. Brieﬂy, the cells were stained with 5.0 lg/ml
of propidium iodide and analyzed using a CellLab Quanta™ Flow
Cytometer from Beckman-Counter™. Adherent WWT and WKO
cells were plated at 4  104 cells/cm2 in a 6-well plate, and after
24 h, they were treated with a 1.0 mM hydrogen peroxide solution
for the indicated time, trypsinized, combined with detached cells,
washed with PBS and stained; the samples were then counted by
cytoﬂuorimetric analyses. The experiments were repeated at least
ﬁve times, and the results displayed reproducibility. The data were
analyzed using the WinMDI 2.8 software.
2.7. Statistical analyses
All experiments were repeated at least ﬁve times (unless other-
wise stated), and the data are expressed as the mean values and
standard deviation. The differences between means were assessed
using one-way ANOVA with Bonferroni’s post-test; p values <0.05
were considered signiﬁcant.
Fig. 1. Isolated PrPC reduces the rate of ROS generation in an oxidant mixture. A
puriﬁed DMPO solution (80 mM) was used as spin trap. The spectra were measured
after and during the reaction using a gain of 2.00  104, a modulation amplitude of
1 G, a time constant of 40.96 ms. The [DMPO-OH] was estimated by double
integration using TEMPOL (1–100 lM) as the standard. The graph indicates the
mean from three independent sets of experiments.
Fig. 2. The effects of hydrogen peroxide treatment on ROS generation in astrocytes:
PrPC knockout cells generate more intracellular ROS. WKO and WWT cells were
treated with H2O2 at 3 mM for 3, 6 and 24 h. The cells were then incubated with
50 lM DCFH-DA for 30 min at 37 C and washed 3 times with PBS. The reported
ﬂuorescence (absolute units) was measured at 525 nm in a ﬂuorescence spectro-
photometer. The assays were conducted in quintuplicate for both cultured cell
types, WWT and WKO. The data are the mean values ± standard deviations (n = 5).
The signiﬁcant differences between the WWT (wt for PrPC) and WKO cells
(knockout for PrPC) are indicated by asterisks (p < 0.05 (⁄)).
Table 1
Percentage of WWT cells in the different cell cycle phases. The control refers to cells
without H2O2 treatment. The data are presented as the mean values ± standard
deviations (n = 5).
Wild-type (%)
SubG1 G1 S G2/M
24 h
Control 7.5 ± (0.4) 17.9 ± (0.4) 48.9 ± (0.7) 22.5 ± (0.5)
H2O2 12.4 ± (0.2) 14.3 ± (0.6) 44.7 ± (1.8) 22.8 ± (1.1)
48 h
Control 8.0 ± (0.4) 17.5 ± (0.9) 45.2 ± (2.0) 28.0 ± (1.4)
H2O2 27.5 ± (1.4) 9.1 ± (0.5) 36.0 ± (1.8) 21.0 ± (1.1)
Table 2
Percentage of WKO cells in the different cell cycle phases. The control refers to cells
without H2O2 treatment. The data are presented as the mean values ± standard
deviations (n = 5).
Knock-out (%)
SubG1 G1 S G2/M
24 h
Control 6.3 ± (0.1) 6.0 ± (0.3) 57.5 ± (0.2) 28.7 ± (1.2)
H2O2 20.8 ± (0.9) 4.1 ± (0.2) 39.8 ± (2.0) 27.3 ± (1.4)
48 h
Control 20.7 ± (0.8) 5.5 ± (0.3) 39.1 ± (1.1) 32.3 ± (1.2)
H2O2 54.1 ± (2.7) 33.8 ± (1.7)*
* Differentiation of phase was not observed in this case.
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3.1. The PrPC protein decreases free radical generation in solution
The cellular prion protein is known to reduce oxidative stress in
cells; PrPC-deﬁcient cells exhibit a high Mn-Superoxide dismutase
activity, which results in reduced cell defenses [27]. Thereafter,
based on these ﬁndings, discordant studies were performed to
establish whether the prion protein has an SOD1-like activity
[39]. On one hand, Brown and colleagues claimed to have found
an SOD1-like activity for PrPC in experiments where the concentra-
tion of PrPC reached 10 mg/ml. On the other hand, using several
conditions and different proteins, Jones et al. [40] showed that PrPC
displayed SOD1-like activity, but this activity was low and ap-
peared to be inherent to virtually any protein. In establishing our
model, we extrapolated the values obtained by Brown et al. [27]
for similar assays using a range of concentrations, 30–100 mg/ml,of puriﬁed mouse wt PrPC and mouse PrPCdel[51-91], and we com-
pared the SOD1-like activity to a positive control, SOD1. We con-
cluded that the SOD-like activity displayed by these proteins is
almost negligible compared with SOD1 (data not shown).
On the other hand, we observed that the isolated PrPC protein in
solution could decrease the concentration of the DMPO-OH radical
adduct generated in an oxidant system (copper(II)/ascorbate/
H2O2). The generation of radicals in this Fenton mixture, which
comprised hydroxyl radicals, was measured through the nitrone
DMPO, and the concentration was determined by measuring the
area under the peak [41]. The presence of soluble PrPC in this oxi-
dant solution reduced the concentration of DMPO-OH by 45–70%
depending on the protein concentration. The best result was ob-
tained for a 3.0 lM concentration of PrPC (Fig. 1) with 70% less
DMPO-OH trapped and measured in the system.3.2. PrPC is necessary for astrocytes in culture to reduce ROS
generation under oxidative stress
WKO, which is an astrocyte cell line derived from PrPC knockout
mice, andWWT, the wild type counterpart, have been used to eval-
uate the resistance of glia cells without PrPC to ROS generation and
oxidative stress caused by exogenous hydrogen peroxide. We have
quantiﬁed the level of intracellular ROS formed after the cells were
exposed to H2O2 using the membrane-permeable non-ﬂuorescent
cell probe DCFH-DA, which has a highly ﬂuorescent oxidized form
(20,70-dichloroﬂuorescein; DCF) [42,43]. After 24 h of treatment
with H2O2, the untreated cells had a weak ﬂuorescence intensity,
which varied little with respect to time (data not shown). In con-
trast, incubation with an internal ROS source resulted in an early
and rapid increase in ﬂuorescence only in WKO cells (Fig. 2) for
three hours before the ﬂuorescence returned to the levels observed
for WWT cells. Thus, WKO cells generated a swift increase, which
could correspond to a protective role for PrPC, and the decrease
in ﬂuorescence intensity observed later resulted from compensa-
tory mechanisms.
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stress conditions
Cell cycle measurements can be a useful tool to verify the inﬂu-
ence of oxidant treatment in cell culture [44]. The modality of cyto-Fig. 3. The effects of hydrogen peroxide treatment on the astrocyte cell cycle: PrPC knock
phase. Both WKO and WWT were treated with 1 mM H2O2 for 24 and 48 h. The cells
apoptosis through cytoﬂuorimetric analyses. The reported cell cycle plots and the perce
times that produced similar results. (A) WWT; (B) WKO. The control refers to cells withtoxic effects caused by hydrogen peroxide in cultured astrocytes
was assessed by cytoﬂuorimetric analyses after staining the cell
DNA with the ﬂuorochrome propidium iodide. As expected and
shown in Fig. 3A, 48 h of treatment with H2O2 promoted WWT cell
progression towards the sub-G1 (apoptotic) phase compared without cells (WKO) are less resistant and had a higher percentage of cells in the sub-G1
were then treated with propidium iodide to determine cell cycle progression and
ntage of nuclei in the different phases are from a typical experiment performed 5
out H2O2 treatment.
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However, in WKO cells, the intense cell cycle arrest was followed
by an increased percentage of the sub-G1 population after treat-
ment for 24 h, and after 48 h more than a half of the population
was in the sub-G1 phase (see Table 2). The low population ob-
served in the ﬂow cytometry was due to the high mortality of
the WWO cells under oxidant treatment. Even without treatment
PrPC knockout astrocytes, shown a higher population in the sub-
G1 phase (Fig. 3B) compared with the wt astrocytes (Fig. 3A).
Moreover, no signiﬁcant cell cycle arrest in the G1 or G2/M
phases was observed during the treatment of these cells (see
Tables 1 and 2).
4. Discussion
The antioxidant activity of the prion protein has been highly
discussed in the literature, especially with reference to its potential
superoxide dismutase-like activity [39,45]. The source for this
interest is likely that PrPC binds 4 or 5 copper ions in its structure,
and as copper is a redox-active metal ion, it is probable that PrPC
participates in a redox process as a ROS scavenger or a general anti-
oxidant protein. Herein, we quantiﬁed the ROS scavenger activity
of PrPC in vitro and demonstrated its importance for astrocyte sur-
vival in an oxidative environment.
Free radical generation in solution, which includes hydroxyl
radicals, can be measured by the nitrone DMPO in a competitive
manner compared with other redox sensitive species in the med-
ium. We observed that PrPC in the oxidant medium is associated
with an approximately 70% decrease in the radical adduct DMPO/
OH concentration. Similarly, we demonstrated that PrPC in solu-
tion can act as a hydroxyl radical scavenger and prevent the radi-
cals from reacting with the trap DMPO.
In cultured astrocytes generated from wild type and PrPC
knockout mice, an oxidant medium was added, and both ROS
scavenger activity and cell cycle progression were examined un-
der these conditions. The concept that redox cycling controls the
mammalian cell cycle through modulation of intracellular anti-
oxidant/oxidant species has received much consideration in the
literature [46]. In this study, the absence of PrPC caused abnor-
mal elevations in ROS accumulation in the astrocytes over the
ﬁrst 3 h of treatment. Moreover, we linked this increase in
ROS levels to strong alterations in the cell cycle, including an in-
crease in the sub-G1 phase cells after 24 and 48 h of oxidant
treatment.
As expected, H2O2, which is a strong ROS generator, promotes
apoptosis in cells after 24 h, and this effect is stronger at 48 h
but only when PrPC is absent in astrocytes. In wild type cells,
the oxidant treatment increased the amount of apoptotic cells
after 48 h and the proportion of cells in the sub-G1 phase by
27%, which was much less than in the PrPC knockout cells. These
results suggest that PrPC is important for reducing hydrogen per-
oxide toxicity in astrocytes, which prevents the cell death inde-
pendently of an SOD-like activity. This ﬁnding raises the
following questions: how does PrPC mediates such activity, if
other partners of this modulating protein are involved, and
importantly, what is the importance of such anti-redox activity
in the context of neurodegenerative diseases.
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